Faster and safer safety cabinet fumigation

Published: 18-Feb-2011
Containment Manufacturing Ingredients Regulatory Cleaning

Hydrogen peroxide system offers alternative to toxic formaldehyde fumigation of safety cabinets

New from isolator producer Skan AG is the Skanair DECOSIS fumigation system, which eliminates biosafety risks prior to the maintenance of microbiological safety cabinets and other biocontainment units.

An easier and faster alternative to formaldehyde fumigation, the Skanair DECOSIS is a mobile unit used directly in the lab, and connected to the safety cabinet via two tubes. It functions autonomously thanks to a control system and catalytic converter.

Because it uses hydrogen peroxide (H2O2) as a biocide, decomposition products are unproblematic, and maintenance work can subsequently be safely carried out on the decontaminated cabinet.

The unit can be used to decontaminate microbiological safety cabinets in advance of maintenance work, when changing job or location, in preparation for disposal, or in the event of breakdowns or accidents.

It can also be used to decontaminate incubators, air locks and small isolators.

The cabinet continues to run in reduced mode throughout the procedure. The trained maintenance technician enters the corresponding facility parameters at a control system display, together with the quantity of H2O2 defined on the basis of the Skanair DECOSIS validation.

The process starts at the touch of a button, and runs completely automatically: the internal ventilation unit maintains slight negative pressure and feeds H2O2 vapour through the front cover into the cabinet, continuously circulating it inside the cabinet to reach all contaminated areas. The exhaust air through the cabinet‘s HEPA filter is then fed back into the Skanair DECOSIS via the second tube to be recirculated.

The decontamination phase is followed by the flushing phase: any biocides in the exhaust air from the cabinet are removed inside the Skanair DECOSIS via a catalytic converter and a final HEPA filter. This air can then be released directly into the lab, without having to be extracted via the building exhaust air system.

See more

You may also like

Containment

Ajinomoto Bio-Pharma Services expands fill-finish with new suite

Read more
The biopharma CDMO has announced it will soon open a high-speed multi-purpose fill-finish line in its commercial manufacturing facility located in San Diego, CA

Trending Articles

  1. FDA approves AstraZeneca's FASENRA for hypereosinophilic syndrome AstraZeneca's FASENRA has received FDA approval for hypereosinophilic syndrome in adults and adolescents aged 12 and above, based on Phase III NATRON trial data showing a 65% reduction in the risk of first HES flare compared to placebo
  2. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  3. How the QA and QP Talent Market Is Changing in Pharma: Insights from Compliance Unlocked Podcast Recruiting and retaining experienced quality and regulatory professionals has become significantly more complex for pharmaceutical and biotech companies
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards

Upcoming event

Cleanroom Technology Conference UK

20-21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Containment

Ajinomoto Bio-Pharma Services expands fill-finish with new suite

The biopharma CDMO has announced it will soon open a high-speed multi-purpose fill-finish line in its commercial manufacturing facility located in San Diego, CA
Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing

Piramal Pharma Solutions announces partnership with Botanix to support drug substance development

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Subscribe now